US81642T2096
US81642T2096
SELLAS Life Sciences Group, Inc
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 75/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±97.4% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 2.6x as much as the broader market.
Beta (Market Relation)
2.57x
Above averageVolatility (5Y p.a.)
97.4% p.a.
5-Year HorizonMax Drawdown (5Y)
-94.7%
5-Year HorizonSharpe Ratio
0.03
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +483.4% |
| 3 Years | 96.5% | -64.3% | 1 | +98.9% |
| 5 Years | 97.4% | -94.7% | 0.03 | +5.3% |
| 10 Years | 128.2% | -100.0% | -0.4 | -48.7% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
High market risk: Beta of 2.57 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (97.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -100.0% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
6 ISS Score: 6 / 10
Audit Risk
6 ISS Score: 6 / 10
Board Risk
5 ISS Score: 5 / 10
Short Ratio
7.61